Elucidating the role of TWIST1 in ulcerative colitis: a comprehensive bioinformatics and machine learning approach.

Background: Ulcerative colitis (UC) is a common and progressive inflammatory bowel disease primarily affecting the colon and rectum. Prolonged inflammation can lead to colitis-associated colorectal cancer (CAC). While the exact cause of UC remains unknown, this study aims to investigate the role of the TWIST1 gene in UC. Methods: Second-generation sequencing data from adult UC patients were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were identified, and characteristic genes were selected using machine learning and Lasso regression. The Receiver Operating Characteristic (ROC) curve assessed TWIST1's potential as a diagnostic factor (AUC score). Enriched pathways were analyzed, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Variation Analysis (GSVA). Functional mechanisms of marker genes were predicted, considering immune cell infiltration and the competing endogenous RNA (ceRNA) network. Results: We found 530 DEGs, with 341 upregulated and 189 downregulated genes. TWIST1 emerged as one of four potential UC biomarkers via machine learning. TWIST1 expression significantly differed in two datasets, GSE193677 and GSE83687, suggesting its diagnostic potential (AUC = 0.717 in GSE193677, AUC = 0.897 in GSE83687). Enrichment analysis indicated DEGs associated with TWIST1 were involved in processes like leukocyte migration, humoral immune response, and cell chemotaxis. Immune cell infiltration analysis revealed higher rates of M0 macrophages and resting NK cells in the high TWIST1 expression group, while TWIST1 expression correlated positively with M2 macrophages and resting NK cell infiltration. We constructed a ceRNA regulatory network involving 1 mRNA, 7 miRNAs, and 32 long non-coding RNAs (lncRNAs) to explore TWIST1's regulatory mechanism. Conclusion: TWIST1 plays a significant role in UC and has potential as a diagnostic marker. This study sheds light on UC's molecular mechanisms and underscores TWIST1's importance in its progression. Further research is needed to validate these findings in diverse populations and investigate TWIST1 as a therapeutic target in UC.

Advances in the treatment of malignant ascites in China.

PURPOSE: Malignant ascites (MA) often occurs in recurrent abdominal malignant tumors, and the large amount of ascites associated with cancerous peritonitis not only leads to severe abdominal distension and breathing difficulties, but also reduces the patient's quality of life and ability to resist diseases, which usually makes it difficult to carry out anti-cancer treatment. The exploration of MA treatment methods is also a key link in MA treatment. This article is going to review the treatment of MA, to provide details for further research on the treatment of MA, and to provide some guidance for the clinical treatment of MA. METHOD: This review analyzes various expert papers and summarizes them to obtain the paper. RESULT: There are various treatment methods for MA, including systemic therapy and local therapy. Among them, systemic therapy includes diuretic therapy, chemotherapy, immunotherapy, targeted therapy, anti angiogenic therapy, CAR-T, and vaccine. Local therapy includes puncture surgery, peritoneal vein shunt surgery, acellular ascites infusion therapy, radioactive nuclide intraperitoneal injection therapy, tunnel catheter, and intraperitoneal hyperthermia chemotherapy. And traditional Chinese medicine treatment has also played a role in enhancing efficacy and reducing toxicity to a certain extent. CONCLUSION: Although there has been significant progress in the treatment of MA, it is still one of the clinical difficulties. Exploring the combination or method of drugs with the best therapeutic effect and the least adverse reactions to control MA is still an urgent problem to be solved.

ZnO nanoparticles mediated by Azadirachta indica as nano fertilizer: Improvement in physiological and biochemical indices of Zea mays grown in Cr-contaminated soil.

The current investigation aimed at evaluating the impact of Azadirachta indica-mediated zinc oxide nanoparticles (Ai-ZnONPs) on the growth and biochemical characteristics of maize (sweet glutinous 3000) under exposure to 50 mg kg-1Ai-ZnONPs with Cr (VI) concentrations of 50 and 100 mg kg-1. The results indicate that plants exposed to Cr (VI) only experienced a decline in growth parameters. Conversely, the inclusion of Ai-ZnONPs caused a noteworthy increase in physiological traits. Specifically, shoot and root fresh weight increased by 28.02% and 16.51%, and 63.11% and 97.91%, respectively, when compared to Cr-50 and 100 treatments. Additionally, the SPAD chlorophyll of the shoot increased by 91.08% and 15.38% compared to Cr-50 and 100 treatments, respectively. Moreover, the antioxidant enzyme traits of plant shoot and root, such as superoxide dismutase (SOD 7.44% and 2.70%, and 4.45% and 3.53%), catalase (CAT 1.18% and 3.20%, and 5.03% and 5.78%), and peroxidase (POD 0.31% and 5.55%, and 4.72% and 3.61%), exhibited significant increases in Cr 50 and 100 treatments, respectively. The addition of Ai-ZnONPs to the soil also enhanced soil nutrient status and reduced Cr (VI) concentrations by 40.69% and 19.82% compared to Cr-50 and 100 treated soils. These findings suggest that Ai-ZnONPs can trigger the activation of biochemical pathways that enable biomass accumulation in meristematic cells. Further investigations are required to elucidate the mechanisms involved in growth promotion.

Evaluating the Combined Effects of Erythromycin and Levofloxacin on the Growth of Navicula sp. and Understanding the Underlying Mechanisms.

Navicula sp., a type of benthic diatom, plays a crucial role in the carbon cycle as a widely distributed algae in water bodies, making it an essential primary producer in the context of global carbon neutrality. However, using erythromycin (ERY) and levofloxacin (LEV) in medicine, livestock, and aquaculture has introduced a new class of pollutants known as antibiotic pollutants, which pose potential threats to human and animal health. This study aimed to investigate the toxic effects of ERY and LEV, individually or in combination, on the growth, antioxidant system, chlorophyll synthesis, and various cell osmotic pressure indexes (such as soluble protein, proline, and betaine) of Navicula sp. The results indicated that ERY (1 mg/L), LEV (320 mg/L), and their combined effects could inhibit the growth of Navicula sp. Interestingly, the combination of these two drugs exhibited a time-dependent effect on the chlorophyll synthesis of Navicula sp., with ERY inhibiting the process while LEV promoted it. Furthermore, after 96 h of exposure to the drugs, the activities of GSH-Px, POD, CAT, and the contents of MDA, proline, and betaine increased. Conversely, the actions of GST and the contents of GSH and soluble protein decreased in the ERY group. In the LEV group, the activities of POD and CAT and the contents of GSH, MDA, proline, and betaine increased, while the contents of soluble protein decreased. Conversely, the mixed group exhibited increased POD activity and contents of GSH, MDA, proline, betaine, and soluble protein. These findings suggest that antibiotics found in pharmaceutical and personal care products (PPCPs) can harm primary marine benthic eukaryotes. The findings from the research on the possible hazards linked to antibiotic medications in aquatic ecosystems offer valuable knowledge for ensuring the safe application of these drugs in environmental contexts.